Effect of potassium citrate therapy on stone recurrence and regrowth after extracorporeal shockwave lithotripsy in children

BACKGROUND AND PURPOSE: Stone disease in children may cause functional and morphologic changes in the urinary tract during longer-term follow-up. Prevention of stone recurrence will be possible only with careful metabolic evaluation and appropriate management. The possible preventive effects of potassium citrate therapy on true stone recurrence, as well as regrowth rates after shockwave lithotripsy (SWL), were evaluated in children treated for renal stones. PATIENTS AND METHODS: Following assessment of the efficacy of SWL, 96 children (72 male, 53 female aged 4 to 14 years with a mean of 6.6 years) were evaluated for the effects of potassium citrate on residual fragments as well as true new stone formation during long-term follow-up. All children had calcium-containing stones with normal renal morphology and function without any urinary-tract infection. Depending on the outcome of treatment, patients with and without residual stones were allocated independently to Group I (N = 52) and Group II (N = 44), which were matched for sex and age. Group I was given oral potassium citrate 1 mEq/kg daily for 12 months; the remaining children served as controls. Follow-up ranged from 12 to 36.6 months, with a mean of 24.4 months. Follow-up results for at least a year with respect to the stone recurrence or stone growth rates were recorded in both groups. RESULTS: Stone-free children undergoing no specific therapy had significant new stone formation compared with the group receiving potassium citrate on a regular basis (34.6% and 7.6%, respectively). Children with residual fragments receiving no specific preventive measure also showed significant new stone formation, along with enlargement of the fragments. CONCLUSION: In addition to stone removal, treatment of pediatric urolithiasis requires a thorough metabolic evaluation. Depending on the abnormalities, each patient should be advised on adequate drinking to increase the urine volume in accordance with body size. Although children with hypocitraturia may well benefit from therapeutic agents that raise the urine citrate concentration, our results did clearly show that all children bearing residual fragments should be counseled on adequate fluid intake along potassium citrate treatment to prevent stone regrowth or formation during long-term follow-up.     

Effect of vibration massage therapy after extracorporeal shockwave lithotripsy in patients with lower caliceal stones

PURPOSE: To determine whether vibration massage influences the results of extracorporeal shockwave lithotripsy (SWL) in patients with lower caliceal stones. PATIENTS AND METHODS: One hundred three patients with lower caliceal stones were entered in the study. Patients were divided into two groups that received either SWL alone (Group A, N = 52) or with vibration massage (Group B, N = 51). There was no statistically significant difference between the two groups in stone size, duration of follow-up, or patient age. The complication, stone-free, and stone recurrence rates of the groups were compared. RESULTS: There was no statistically significant difference between the groups in the number of shockwaves, number of SWL sessions, or shockwave energy. The renal colic rate was higher in Group B than in Group A (P = 0.03). The stone-free rates in Group A and Group B were 60% and 80%, respectively (P = 0.003). The stone recurrence rate was higher in Group A than in Group B (P = 0.0006). CONCLUSIONS: This retrospective study demonstrates that SWL with vibration massage appears to have a beneficial effect on the passage of fragments in patients with lower caliceal stones.     

Post-extracorporeal shockwave lithotripsy residual stone fragments: clinical significance and management

Although extracorporeal shockwave lithotripsy (ESWL) is one of the primary treatments for urolithiasis, very often residual fragments of the calculi are still present for a long time after the ESWL session. These fragments are usually asymptomatic and can be managed expectantly, but sometimes they can cause symptoms and require intervention. Secondary procedures are not routinely applied to all patients with residual fragments, but only to those with significant symptoms. Medical therapy may play an important role in the management of residual fragments, by correcting an underlying metabolic disorder and by preventing the growth of residual calculi and the formation of new ones.     

Impact of fasting on shockwave lithotripsy in renal stones: a randomized controlled trial

PURPOSE: We evaluated the impact of fasting on the effectiveness of shockwave lithotripsy (SWL) in patients with renal calculi. PATIENTS AND METHODS: The study was a randomized controlled trial for patients with renal stones. Between May 2005 and November 2006, patients (n = 97) with a single radio-opaque renal stone (7-21 mm) who were candidates for SWL were enrolled. Patients were randomized to fasting (F, n = 49) and nonfasting (NF, n = 48) groups. F group patients were asked to fast for 12 hours before SWL. Urine specific gravity (SG) was measured after fasting. All patients were monitored every 2 weeks until complete stone clearance. Treatment effectiveness was defined as complete clearance up to 3 months. RESULTS: There were 32 men in the F group and 28 men in the NF group. The mean age was 37.9 +/- 8.5 years in the F group and 39.1 +/- 7.7 years in the NF group. The mean body mass index was 22.8 +/- 2.5 and 23.1 +/- 2.6 in F and NF patients, respectively. The urine SG in the F group (1.036 +/- 0.004) was significantly higher than in the NF group (1.013 +/- 0.004; P < 0.001). At 3-month follow-up, the overall stone-free rate using SWL was 86.1% in the F group, which was higher than the rate of 72.9% in the NF group; however, the difference was not statistically significant (P = 0.16). CONCLUSION: Fasting significantly changes the urine SG but does not have a significant impact on the effectiveness of SWL for isolated renal stones.     

Prophylactic and therapeutic properties of a sodium citrate preparation in the management of calcium oxalate urolithiasis: randomized, placebo-controlled trial

The purpose of this study was to investigate the prophylactic and therapeutic effects of a hitherto untested preparation containing sodium citrate in the management of calcium oxalate urolithiasis. In this study, a host of calcium oxalate kidney stone risk factors was investigated using a randomised, placebo controlled, within-patient clinical trial. The trial involved four groups of subjects: healthy male controls, healthy female controls , calcium oxalate stone-forming males and calcium oxalate stone-forming females. There were 30 subjects in each group. Twenty subjects in each group ingested the preparation containing sodium citrate and ten subjects in each group ingested a placebo for 7 days. Collection of 24 h urines were carried out at baseline, at day 7 and day 10 (i.e. 3 days after suspension of drug/placebo ingestion). These were analysed for biochemical and physicochemical risk factors. They were also tested for their inhibitory properties in crystallization experiments. Data were statistically analyzed using analysis of variance (ANOVA). Key risk factors were significantly and beneficially altered across all groups after ingestion of the preparation. The pH and urinary citrate excretion increased while urinary oxalate and calcium excretions decreased, as did relative supersaturations of calcium oxalate and uric acid. In addition, inhibition of calcium oxalate crystallization increased. Beneficial carryover effects were observed for some risk factors. The results of this study have demonstrated, for the first time, that a sodium citrate-containing preparation favourably alters the risk factors for calcium oxalate urolithiasis.     

Effects of sodium citrate, potassium citrate, and citric acid in preventing experimental calcium oxalate urolithiasis in rats

Male Wistar-strain rats which had been fed a glycolic-acid diet developed severe nephrocalcinosis with urinary calculi within 4 weeks. Rats fed the same diet with citrate salts added had, however, either slight or no nephrocalcinosis without any stones in the urinary system. Nephrocalcinosis intermediate between those in the citrate groups and the glycolic-acid group, with some urinary calculi, was observed in the citric-acid group. During the experiment, the urinary oxalate concentration increased markedly and was higher in the citrate and citric-acid than in the glycolic-acid group. The urinary citrate concentration was significantly higher in the citrate groups and lower in the citric acid and glycolic-acid groups. Therefore, citrate salts can be concluded to inhibit nephrocalcinosis and calculi formation as a result of decreased urinary saturation by means of increase in urinary citrate, in spite of a slight increase in the urinary oxalate.     

Efficacy of extracorporeal shockwave therapy for knee osteoarthritis: a randomized controlled trial

Background

Extracorporeal shockwave therapy (ESWT) has been widely used for pain relief and treatment of musculoskeletal disorders. We aimed to assess ESWT for knee osteoarthritis (OA) over 12 wk by comparison with placebo treatment.

Materials and methods

We randomized 70 patients to receive placebo (n = 36) or ESWT (n = 34). For ESWT, patients received 4000 pulses of shockwave at 0.25 mJ/mm² weekly for 4 wk. In the placebo group, patients received shockwave at 0 mJ/mm² in the same area. The effect on OA was assessed by pain on a visual analog scale and disability on the Lequesne index, Western Ontario and McMaster University Osteoarthritis Index, and patient perception of the clinical severity of OA. Evaluation was performed at baseline and after 1, 4, and 12 wk.

Results

We found no adverse events during and after ESWT. ESWT was more effective than placebo in reducing pain on movement at each period (P < 0.01). The mean visual analog scale score with ESWT was 3.83 at 12 wk versus 7.56 at baseline (P < 0.01). The Lequesne index and the Western Ontario and McMaster University Osteoarthritis Index score were reduced with ESWT. Moreover, patient perception of clinical severity of OA was significantly greater with ESWT than that with placebo (P < 0.01).

Conclusions

ESWT is effective in reducing pain and improving knee function, with better results than placebo during the 12-wk treatment. However, further pilot studies are needed to determine whether ESWT should be recommended at an early or later stage of OA or combined with conventional therapies.     

Inhibition by sodium-potassium citrate (CG-120) of calcium oxalate crystal growth on to kidney stone fragments obtained from extracorporeal shock wave lithotripsy

Retention of fragments within the kidney after extracorporeal shock wave lithotripsy (ESWL) continues to be a major shortcoming of this form of stone treatment. The aim of this study was to evaluate the ability of sodium-potassium citrate to inhibit calcium oxalate crystal nucleation and growth on to stone fragments remaining after ESWL. The continuous flow crystallisation technique was adapted to induce calcium oxalate crystal nucleation and growth on to the surface of fragmented kidney stones and the inhibitory effect of sodium-potassium citrate was assessed by scanning electron microscopy and by determining the relative increase in crystalline mass at final concentrations of 0, 2, 4, 6, 8, 10 mmol/l. Sodium-potassium citrate significantly inhibited the deposition of new crystalline calcium oxalate in a dose-dependent manner above 2 mmol/l; these findings were confirmed by scanning electron microscopy. It was concluded that sodium-potassium citrate may provide an effective means of preventing the formation of new kidney stones by the deposition of calcium oxalate on to residual stone fragments resulting from ESWL and that the technique used is an efficient means of testing the efficacy of therapeutic agents to prevent stone recurrence in patients treated with ESWL.     

Extracorporeal shockwave therapy in the management of plantar fasciitis: A randomized controlled trial

BackgroundThis study aimed at estimating the extent to which a combination therapy of extracorporeal shockwave therapy (ESWT) with usual care (exercise and orthotic support) improve functional ability in the patient with plantar fasciitis when compared to usual care alone.MethodsParticipants with plantar fasciitis were randomly allocated into two groups: ESWT (n = 23), and control (n = 21). All participants received home exercise program with orthotic support. In addition, ESWT group received 2000 shock waves with 0.02 mJ/mm² for three sessions. Functional outcomes were measured by function subscale of American orthopedic foot and ankle society (AOFAS-F) score and 12 minutes walking test including walking speed, cadence. The scores were recorded at baseline, third week and third month after the treatment. Analysis was performed using repeated measures ANOVA, and an intention to treat approach using multiple imputations.ResultsResults showed that there was a significant improvement in AOFAS-F total score and walking speed over three months in both groups (p < 0.001, p = 0.04 respectively); improvements in AOFAS-F were particularly in activity limitation (p = 0.001), walking distance (p = 0.02) and walking surface (p = 0.02). Groups were comparable with each other for both walking speed and AOFAS-F in any assessment time (p > 0.05). However, groups performed differently in cadence where there was an increase in cadence in ESWT group whereas a decline in control at the third month (p = 0.07).ConclusionThe results revealed that ESWT did not have an additive benefit over usual care to improve foot function and walking performance in patient with plantar fasciitis over three months post-treatment.     

Potassium citrate vs. hydrochlorothiazide to reduce urinary calcium excretion in calcium oxalate stone patients with hypercalciuria: a prospective randomized study

Purpose

Calcium oxalate (Ca-Ox) is the most common stone composition and one of the most common 24-h urine anomalies is hypercalciuria. The purpose of this study was to evaluate the efficacy of potassium citrate (K-CIT) for prevention of hypercalciuria in comparison with hydrochlorothiazide (HCT) in patients with calcium oxalate stones and hypercalciuria.

Materials and methods

In this prospective randomized study, patients were randomized to receive either HCT (50 mg/day) or K-CIT (40 mEq/day) following achieving stone-free status. Treatment was continued for 6 months. 24 h urine analysis was performed prior to treatment and repeated at third month and measured parameters were volume, calcium, oxalate, citrate, sodium, and uric acid. Stone recurrence was evaluated with KUB and ultrasonography at 6th and 12th months.

Results

Data of 40 patients in each arm were evaluated. Mean 24 h urine calcium levels decreased to 205?±?54.5 mg/day and 220.6?±?96.3 mg/day in the K-CIT and HCT groups, respectively, and difference was not significant (p?=?0.931). The reduction compared to pretreatment values was statistically significant in both groups. Urinary citrate levels also significantly increased in both groups and level of increase was significantly higher in K-CIT group. At 12th month, ultrasonography revealed stones in two patients in HCT group, and in one patient in the K-CIT group.

Conclusions

K-CIT provided significantly reduced calcium and increased citrate excretion in patients Ca-Ox stone patients with hypercalciuria. The efficacy in decreasing calcium excretion was comparable to HCT treatment. K-CIT can be used for medical prophylaxis of Ca-OX stone patients with hypercalciuria.

     

The impact of caliceal pelvic anatomy on stone clearance after shock wave lithotripsy for pediatric lower pole stones

PURPOSE: The clearance rather than stone disintegration of lower pole stones after shock wave lithotripsy (SWL) is significantly inferior according to the other localizations of the kidney. We retrospectively evaluated the impact of caliceal pelvic anatomy on stone clearance after SWL for pediatric lower pole stones. MATERIALS AND METHODS: We treated 163 renal units (RUs) in children 16 years old or younger with SWL between March 1992 and February 2002. In 36 RUs stones were localized in the lower calices. All patients were treated with sedoanalgesia except 3 (8%) who were treated under general anesthesia. Patients were evaluated by excretory urography and ultrasonography 12 weeks after the last session, and were designated as stone-free or with residual stone. The lower infundibular length, width, length-to-width ratio, pelvic caliceal height and lower infundibulopelvic angle were determined on standard excretory urography before SWL. All measurements were done by 1 urologist who was unaware of the results. Statistical analysis was performed with chi-square, Fisher's exact and Mann-Whitney U tests. ROC analysis was done to determine the cutoff points of caliceal anatomy measurements for stone clearance. RESULTS: We treated 36 RUs in 23 males and 10 females with isolated lower caliceal stones. Median patient age was 10.5 years (range 2 to 16). Median stone burden was 0.7 cm (range 0.2 to 4), and median number of shock waves and energy used for the entire patient population was 1,500 and 17.2 kV, respectively. Overall stone-free rates for the 36 RUs were 61% after a median treatment session of 1 (range 1 to 7) and retreatment rates were 39%. Of the patients rendered free of stones 13 (59%) were treated in a single SWL session and 9 (41%) underwent 2 or more sessions. Median lower infundibular length, width, length-to-width ratio and pelvic caliceal height in the stone-free and residual stone group were 25.5, 28.0 mm, 4.5, 5.0 mm, 6.4, 5.5 mm and 21.5, 21.5 mm, respectively (p = 0.810, 0.327, 0.511 and 0.511). Median lower infundibulopelvic angle in the stone-free and residual stone groups was 92.50 and 92.50 degrees, and 60.0 and 54.50 degrees, respectively (p = 0.860 and 0.089). On ROC analysis no parameter predicting stone-free rate and cutoff points of caliceal anatomy measurements for stone clearance was found. CONCLUSIONS: Our results suggest that caliceal pelvic anatomy in pediatric lower pole stones has no significant impact on stone clearance after SWL. There was a highly significant relation between retreatment rates and stone burden, which should be considered for determining the treatment modality.